Article
Reversion of recombinant toxoids: mutations in diphtheria toxin that partially compensate for active-site deletions.
Proceedings of the National Academy of Sciences of the United States of America - 1 Jul 1992
Killeen K P, Escuyer V, Mekalanos J J, Collier R J
Abstract excerpt
Deleting an important active-site residue of diphtheria toxin, glutamic acid-148, reduces the toxin's ADP-ribosyltransferase activity by a factor of greater than 10(4). We considered using this mutation to construct a recombinant toxoid for expression by live attenuated vaccines and explored second-site mutations that might cause reversion. Activity was partially restored by substituting glutamic acid for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
